Bayer AG Digital Transformation Strategy Report 2025: Accelerators, Incubators, And Innovation Programs

(MENAFN- GlobeNewsWire - Nasdaq) Bayer AG's market opportunities include advancing in human health and agriculture through digital transformation, innovation programs, and strategic partnerships. Focus on new medicine and agricultural technologies, supported by insights on tech initiatives, offers robust growth prospects globally.

Dublin, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Bayer AG 2025" company profile has been added to ResearchAndMarkets's offering.

The report provides insights into company's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.
Bayer AG (Bayer) carries out the discovery, development, manufacturing, and commercialization of products for human health, and agriculture. It provides medicines for cardiovascular diseases, women's health, cancer, hematology, ophthalmology, and other indications. It also strives to develop new molecules and technologies for use in the fields of medicine and modern agriculture.

The company's product portfolio includes prescription products, specialty pharmaceuticals, diagnostic imaging equipment, non-prescription (over-the-counter or OTC) products, seeds, crop protection solutions and non-agricultural pest control solutions. Bayer markets its products through wholesalers, pharmacies, hospitals, and retailers. It operates through a network of subsidiaries in Asia-Pacific, Europe, North America, Latin America, Africa, and the Middle East.
The report provides information and insights into Bayer's tech activities, including:

• Insights of its digital transformation strategies and innovation programs.
• Overview of technology initiatives covering partnerships, product launches, investments, and acquisitions.
• Insights on each technology initiative including technology theme, objective, and benefits.
• Details of estimated ICT budgets and major ICT contracts.

Reasons to Buy

• Gain insights into Bayer's tech operations.
• Gain insights into its tech strategies and innovation initiatives.
• Gain insights into its technology themes under focus.
• Gain insights into various product launches, partnerships, investments, and acquisitions.

Key Topics Covered:

• Overview
• Digital Transformation Strategy
• Accelerators, Incubators, and Innovation Programs
• Technology Focus
• Technology Initiatives
• Investments
• Acquisitions
• Partnership, Investments, and Acquisition Network Map
• ICT Budget
• Key Executives

Companies Featured

• Source
• ConcertAI
• Elaniti
• Segmed
• ZS
• OMP
• Rad AI
• Huma Therapeutics
• Microsoft
• Ada Health
• One Drop
• Recursion Pharmaceuticals
• Schrodinger
• Blackford Analysis
• Exscientia
• Ceres AI
• Intellias
• VeChain
• Google
• Veeva Systems
• Zone Agtech
• Axceta
• Samsung
• Luxsonic
• Capgemini
• Broad Institute
• Belief BioMed

For more information about this company profile visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN17092025004107003653ID1110073827